Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

The aim of this study was to evaluate the efficacy of high-dose paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. Paclitaxel was administered intravenously over 3 h at a dose of 225 mg m(-2) on a 21-day cycle for six courses. Thirty-six patients were entered into t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gore, M. E., Rustin, G., Slevin, M., Gallagher, C., Penson, R., Osborne, R., Ledermann, J., Cameron, T., Thompson, J. M.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group|1 1997
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063326/
https://ncbi.nlm.nih.gov/pubmed/9043029
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars